Literature DB >> 22454880

The clinical significance of indomethacin-probenecid interaction.

P M Brooks1, M A Bell, R D Sturrock, J P Famaey, W C Dick.   

Abstract

1 The effect of the addition of probenecid to oral and rectal regimes of indomethacin was studied in three groups of rheumatoid arthritic patients. 2 The addition of probenecid increases plasma levels of indomethacin given both orally and rectally and significantly reduces the clinical parameters of joint inflammation. 3 The use of probenecid with indomethacin at night may be useful in reducing morning stiffness and pain. 4 Though indomethacin plasma levels are markedly raised during concurrent probenecid therapy remarkably few side effects were observed.

Entities:  

Year:  1974        PMID: 22454880      PMCID: PMC1402433          DOI: 10.1111/j.1365-2125.1974.tb00254.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  THE METABOLITES OF INDOMETHACIN, A NEW ANTI-INFLAMMATORY DRUG.

Authors:  R E HARMAN; M A MEISINGER; G E DAVIS; F A KUEHL
Journal:  J Pharmacol Exp Ther       Date:  1964-02       Impact factor: 4.030

2.  208.--INDOMETHACIN IN THE TREATMENT OF ACUTE GOUT.

Authors:  P L BOARDMAN; F HARTDUDLEY
Journal:  Practitioner       Date:  1965-04

3.  DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.

Authors: 
Journal:  Ann Rheum Dis       Date:  1959-03       Impact factor: 19.103

4.  An assessment of grip strength measurement in rheumatoid arthritis.

Authors:  P Lee; A Baxter; W C Dick; J Webb
Journal:  Scand J Rheumatol       Date:  1974       Impact factor: 3.641

5.  The metabolism of indomethacin in man.

Authors:  D E Duggan; A F Hogans; K C Kwan; F G McMahon
Journal:  J Pharmacol Exp Ther       Date:  1972-06       Impact factor: 4.030

6.  The effect of aspirin on serum indomethacin.

Authors:  G D Champion; H E Paulus; E Mongan; R Okun; C M Pearson
Journal:  Clin Pharmacol Ther       Date:  1972 Mar-Apr       Impact factor: 6.875

7.  Editorial: Pharmacokinetics--master or servant?

Authors:  C T Dollery
Journal:  Eur J Clin Pharmacol       Date:  1973-06       Impact factor: 2.953

8.  Simultaneous pharmacokinetics of indomethacin in serum and synovial fluid.

Authors:  H W Emori; G D Champion; R Bluestone; H E Paulus
Journal:  Ann Rheum Dis       Date:  1973-09       Impact factor: 19.103

9.  The renal excretion of indomethacin and its inhibition by probenecid.

Authors:  M D Skeith; P A Simkin; L A Healey
Journal:  Clin Pharmacol Ther       Date:  1968 Jan-Feb       Impact factor: 6.875

10.  Method for assessing therapeutic potential of anti-inflammatory antirheumatic drugs in rheumatoid arthritis.

Authors:  P Lee; J Webb; J Anderson; W W Buchanan
Journal:  Br Med J       Date:  1973-06-23
View more
  7 in total

Review 1.  Correlation plasma levels, NSAID and therapeutic response.

Authors:  J P Famaey
Journal:  Clin Rheumatol       Date:  1985-06       Impact factor: 2.980

2.  The comparative gastric ulcerogenic activities of non-steroid anti-inflammatory drugs.

Authors:  K D Rainsford
Journal:  Agents Actions       Date:  1977-12

3.  Clinical Pharmacokinetics of indomethacin.

Authors:  L Helleberg
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

Review 4.  Drug interactions and clinical pharmacokinetics.

Authors:  M B Kristensen
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

Review 5.  The problems and pitfalls of NSAID therapy in the elderly (Part II).

Authors:  A G Johnson; R O Day
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

Review 6.  Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs). Recognition, management and avoidance.

Authors:  A G Johnson; P Seideman; R O Day
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

Review 7.  Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs.

Authors:  R K Verbeeck; J L Blackburn; G R Loewen
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.